Clinical Trial Update: Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis [Phase 3]

View source ↗

Summary

A phase 3 safety and efficacy study of apremilast in psoriatic arthritis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2016-06-13